Journal of Inflammation

BMC

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Journal of Inflammation is an open-access journal published by BMC in United Kingdom, publishing in english. It is listed in DOAJ and PUBMED according to the sources read. Declared publication charge: 2,390 GBP. Declared review time at DOAJ: 27 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
BMC
ISSN
1476-9255
Country
United Kingdom
Languages
english
Access
Open access
Declared publication charge
2,390 GBP
Articles in DOAJ
626
Declared review time
27 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2004-10-15
  • PUBMED · 2004-09-27
Indexing
DOAJ · PUBMED
APC
2,390 GBP
Declared review time (DOAJ)
27 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

626

Most recent article

3 months ago

Average review time (journal-declared via DOAJ)

27weeks

Works in OpenAlex

871

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

81

i10-index

583

From OpenAlex open data (CC0).

Editorial & policy13
Last DOAJ review date
2026-03-17
Added to DOAJ
2004-10-15
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
LOCKSSPMC
Observed digital preservation (Keepers registry)— snapshot 2026-09-21
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
89%
ORCID iDs in current deposits
4%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity4
Alternate titles
JI
Source type
journal
NLM unique ID (PubMed)
101232234
Classification2

Subjects (DOAJ)

Medicine: Therapeutics. Pharmacology

LCC codes

RM1-950

Subject areas

  • Immune Response and Inflammation
  • Immune Response and Inflammation
  • Asthma and respiratory diseases
  • Asthma and respiratory diseases
  • Immune cells in cancer
  • Immune cells in cancer
  • Neutrophil, Myeloperoxidase and Oxidative Mechanisms
  • Neutrophil, Myeloperoxidase and Oxidative Mechanisms
Show all subjects (50)
  • Adipokines, Inflammation, and Metabolic Diseases
  • Adipokines, Inflammation, and Metabolic Diseases
  • Inflammasome and immune disorders
  • Inflammasome and immune disorders
  • Cell Adhesion Molecules Research
  • Cell Adhesion Molecules Research
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • IL-33, ST2, and ILC Pathways
  • IL-33, ST2, and ILC Pathways
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Sepsis Diagnosis and Treatment
  • Chemokine receptors and signaling
  • Chemokine receptors and signaling
  • Sepsis Diagnosis and Treatment
  • Cytokine Signaling Pathways and Interactions
  • NF-κB Signaling Pathways
  • Cytokine Signaling Pathways and Interactions
  • NF-κB Signaling Pathways
  • Respiratory Support and Mechanisms
  • Respiratory Support and Mechanisms
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Atherosclerosis and Cardiovascular Diseases
  • Atherosclerosis and Cardiovascular Diseases
  • Neonatal Respiratory Health Research
  • Osteoarthritis Treatment and Mechanisms
  • Neonatal Respiratory Health Research
  • Inflammation biomarkers and pathways
  • Rheumatoid Arthritis Research and Therapies
  • Osteoarthritis Treatment and Mechanisms
  • Inflammation biomarkers and pathways
  • Rheumatoid Arthritis Research and Therapies
  • Allergic Rhinitis and Sensitization
  • Cell death mechanisms and regulation
  • Allergic Rhinitis and Sensitization
  • Cell death mechanisms and regulation
  • Heme Oxygenase-1 and Carbon Monoxide
  • Heme Oxygenase-1 and Carbon Monoxide
  • MicroRNA in disease regulation
  • MicroRNA in disease regulation

Keywords (DOAJ)

  • inflammation
  • anti-inflammatory drugs

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: